Собственный капитал и резервы Изменить Дата
Abbott USD 52.06B 69M 2026-03
Agilent USD 7.12B 214M 2026-03
Becton, Dickinson and Co. USD 24.42B 283M 2026-06
Bruker USD 2.44B 67M 2026-06
Cerus USD 64.22M 2.76M 2025-12
Charles River Laboratories USD 2.84B 59.06M 2026-06
Danaher USD 52.58B 368M 2026-06
Haemonetics USD 837.1M 40.78M 2026-06
Illumina USD 2.84B 162M 2026-06
IQVIA Holdings USD 6.17B 50M 2026-06
Merit Medical Systems USD 1.68B 53.08M 2026-06
Mettler Toledo International USD 12.82M 54.71M 2026-06
Myriad Genetics USD 303.9M 33.5M 2026-06
Neogen USD 2.09B 9.5M 2026-03
OraSure Technologies USD 317.78M 4.45M 2026-06
Pacific Biosciences Of California USD -33.21M 35.58M 2026-06
Quidel USD 1.85B 69.1M 2026-03
Revvity USD 7.18B 67.62M 2026-03
STAAR Surgical USD 365.4M 13.03M 2026-06
Thermo Fisher Scientific USD 51.93B 1.6B 2026-03
Waters USD 15.29B 12.73B 2026-03